Author

Boyi Chen

Observed name: B Chen

Institutions: Center for Life Sciences, State Key Laboratory of Membrane Biology, Zhejiang University, Tsinghua University

Observed institutions: Inova Health System, University of Minnesota, Windber Research Institute, Mayo Clinic, Emory University, Georgetown University, Johns Hopkins Medicine, Moffitt Cancer Center, National Cancer Institute, Center for Life Sciences, State Key Laboratory of Membrane Biology, Berry Consultants, LLC (United States), Zhejiang University, Tsinghua University

ORCID: 0009-0007-8965-480X

Observed ORCID: 0009-0007-8965-480X

OpenAlex ID: A5087092418

Small Cell Lung Cancer—An Update on Chemotherapy Resistance

2024 · Qian Ying, Ruiyun Fan, et al. · Current Treatment Options in Oncology · 24

Diagnostic Application of Bronchoalveolar Lavage Fluid Analysis in Cases of Idiopathic Pulmonary Fibrosis in which Diagnosis Cannot Be Confirmed by High-Resolution Computed Tomography

2025 · Boyi Chen, Zhefeng Leng, et al. · Lung · 3

In vivo -compatible spatial multi-omics via hydrogen peroxide-independent APEX2 labeling

2026 · Boyi Chen, Hongyang Guo, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2

Connective tissue disease-associated interstitial lung disease risk of readmission and all-cause mortality: Interpretable machine learning approach

2025 · Boyi Chen, Xixian Hu, et al. · Chronic Respiratory Disease · 1

Convergent Microenvironment Linking Idiopathic Pulmonary Fibrosis and Lung Cancer

2026 · Min Chen, Yeyuan Zhu, et al. · Expert Reviews in Molecular Medicine

Enhanced PAM50 subtyping of breast cancer implemented in the PCAPAM50 R package

2025 · Praveen-Kumar Raj-Kumar, Boyi Chen, et al. · Scientific Reports

CircPTK2 enhances non‐small cell lung cancer proliferation by inhibiting cellular senescence through stabilizing NFYA and elevating FOXM1

2025 · Qiuhui Li, Kun Zhao, et al. · British Journal of Pharmacology

PCAPAM50: Enhanced 'PAM50' Subtyping of Breast Cancer

2024 · Praveen-Kumar Raj-Kumar, Boyi Chen, et al.

Abstract P2-07-03: Refining neoadjuvant predictors of three year distant metastasis free survival: Integrating volume change as measured by MRI with residual cancer burden

2019 · NM Hylton, WF Symmans, et al. · Cancer Research

Works count: 9

Citation count: 30

H-index: 2

I10-index: 1